Investment
Participated in Antiverse's $9.3M Series A to expand its AI antibody design platform.
Antiverse
Every public signal F4 has attached to this firm, with sources and cross-entity links.
Antiverse
Juniper Genomics
Krevera
Copernic Catalysts
Phaseshift Technologies